Overview
Blepharophimosis-intellectual disability syndrome, Ohdo type (also known as Ohdo syndrome or Ohdo blepharophimosis syndrome) is a rare genetic disorder first described by Ohdo and colleagues in 1986. It is characterized by a distinctive combination of facial features, intellectual disability, and congenital anomalies. The hallmark facial feature is blepharophimosis, a narrowing of the eye opening due to small palpebral fissures, often accompanied by ptosis (drooping eyelids). Affected individuals typically present with intellectual disability of variable severity, which may range from mild to severe. Additional features can include a mask-like, expressionless face, a broad and flat nasal bridge, small mouth, and dental anomalies. Congenital heart defects have been reported in some patients, and hearing loss may also occur. The condition affects multiple body systems, including the craniofacial structures, central nervous system, cardiovascular system, and musculoskeletal system. Hypotonia (reduced muscle tone) and feeding difficulties may be present in infancy. Growth may be affected, with some individuals showing short stature. Speech and motor development are typically delayed. The Ohdo type should be distinguished from other forms of blepharophimosis-intellectual disability syndromes, including the Say-Barber-Biesecker-Young-Simpson (SBBYS) variant, which is caused by mutations in the KAT6B gene and has overlapping but distinct features. There is currently no cure or disease-specific treatment for Ohdo-type blepharophimosis-intellectual disability syndrome. Management is supportive and multidisciplinary, focusing on the individual's specific symptoms. This may include surgical correction of ptosis or blepharophimosis to improve vision and appearance, cardiac evaluation and management if heart defects are present, hearing aids for hearing impairment, and early intervention programs including speech therapy, physical therapy, and special education to optimize developmental outcomes. Regular follow-up with a clinical geneticist and relevant specialists is recommended.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Blepharophimosis-intellectual disability syndrome, Ohdo type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Blepharophimosis-intellectual disability syndrome, Ohdo type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Blepharophimosis-intellectual disability syndrome, Ohdo type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Blepharophimosis-intellectual disability syndrome, Ohdo type.
Community
No community posts yet. Be the first to share your experience with Blepharophimosis-intellectual disability syndrome, Ohdo type.
Start the conversation →Latest news about Blepharophimosis-intellectual disability syndrome, Ohdo type
No recent news articles for Blepharophimosis-intellectual disability syndrome, Ohdo type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Blepharophimosis-intellectual disability syndrome, Ohdo type
What is Blepharophimosis-intellectual disability syndrome, Ohdo type?
Blepharophimosis-intellectual disability syndrome, Ohdo type (also known as Ohdo syndrome or Ohdo blepharophimosis syndrome) is a rare genetic disorder first described by Ohdo and colleagues in 1986. It is characterized by a distinctive combination of facial features, intellectual disability, and congenital anomalies. The hallmark facial feature is blepharophimosis, a narrowing of the eye opening due to small palpebral fissures, often accompanied by ptosis (drooping eyelids). Affected individuals typically present with intellectual disability of variable severity, which may range from mild to
How is Blepharophimosis-intellectual disability syndrome, Ohdo type inherited?
Blepharophimosis-intellectual disability syndrome, Ohdo type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Blepharophimosis-intellectual disability syndrome, Ohdo type typically begin?
Typical onset of Blepharophimosis-intellectual disability syndrome, Ohdo type is neonatal. Age of onset can vary across affected individuals.